Malignancies following bilateral salpingo-oophorectomy (BSO)

European Journal of Surgical Oncology

Volumn 32, Issue 10, 2006, Pages 1231-1234

  Gotlieb, W H ^a   Barchana, M ^b   Ben Baruch, G ^c,e   Friedman, E ^d,e  

^a MCGILL UNIVERSITY   (Canada)

^b MINISTRY OF HEALTH   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

Author keywords

Bilateral salpingo oophorectomy; Cancer risk; Primary peritoneal carinomatosis; Prophylactic surgery

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER REGISTRY; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOMATOUS PERITONITIS; ENDOMETRIUM CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; OVARY CANCER; OVARY CYST; PRIORITY JOURNAL; RISK REDUCTION; SALPINGOOOPHORECTOMY; STATISTICAL SIGNIFICANCE; UTERUS MYOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA; FALLOPIAN TUBES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; OVARIECTOMY; PERITONEAL NEOPLASMS;

EID: 33751189164     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.03.021     Document Type: Article

References (27)

1. Gajewski W., and Legare R.D. Ovarian cancer. Surg Oncol Clin N Am 7 (1998) 317-331
2. American Cancer Society. Cancer facts and figures (2003), American Cancer Society, Inc., Atlanta, GA p. 15-6
3. Gatta G., Lasota M.B., and Verdecchia A. Survival of European women with gynaecological tumours, during the period 1978-1989. EUROCARE Working Group. Eur J Cancer 34 (1998) 2218-2225
4. Engel J., Eckel R., Schubert-Fritschle G., et al. Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate. Eur J Cancer 38 (2002) 2435-2445
5. Struewing J.P., Watson P., Easton D.F., Ponder B.A., Lynch H.T., and Tucker M.A. Prophylactic oophorectomy in inherited breast/ovarian cancer families. J Natl Cancer Inst Monogr 17 (1995) 33-35
6. Fong Y.F., Lim F.K., and Arulkumaran S. Prophylactic oophorectomy: a continuing controversy. Obstet Gynecol Surv 53 (1998) 493-499
7. Berchuck A., Schildkraut J.M., Marks J.R., and Futreal P.A. Managing hereditary ovarian cancer risk. Cancer 86 Suppl. 11 (1999) 2517-2524
8. Brekelmans C.T. Risk factors and risk reduction of breast and ovarian cancer. Curr Opin Obstet Gynecol 15 (2003) 63-68
9. Narod S.A., and Foulkes W.D. BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 4 (2004) 665-676
10. Olopade O.I., and Artioli G. Efficacy of risk-reducing salpingo-oophorectomy in women with BRCA-1 and BRCA-2 mutations. Breast J 10 Suppl. 1 (2004) S5-S9
11. Rebbeck T.R. Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 18 Suppl. 21 (2000) 100S-103S
12. Cormio G., Di Vagno G., Di Gesu G., et al. Primary peritoneal carcinoma: a report of twelve cases and a review of the literature. Gynecol Obstet Invest 50 (2000) 203-206
13. Kontoravdis A., Kalogirou D., Antoniou G., Kontoravdis N., Karakitsos P., and Zourlas P.A. Prophylactic oophorectomy in ovarian cancer prevention. Int J Gynaecol Obstet 54 (1996) 257-262
14. Charoenkwan K., Srisomboon J., Suprasert P., Phongnarisorn C., Siriaree S., and Cheewakriangkrai C. Role of prophylactic oophorectomy at the time of hysterectomy in ovarian cancer prevention in Thailand. J Obstet Gynaecol Res 30 (2004) 20-23
15. Piver M.S., Jishi M.F., Tsukada Y., and Nava G. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry. Cancer 71 (1993) 2751-2755
16. Casey M.J., and Bewtra C. Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations. Fam Cancer 3 (2004) 265-281
17. Karlan B.Y., Baldwin R.L., Lopez-Luevanos E., et al. Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening. Am J Obstet Gynecol 180 (1999) 917-928
18. Levine D.A., Argenta P.A., Yee C.J., et al. Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations. J Clin Oncol 21 (2003) 4222-4227
19. Piver M.S. Prophylactic oophorectomy: reducing the U.S. death rate from epithelial ovarian cancer. A continuing debate. Oncologist 1 (1996) 326-330
20. Abeliovich D., Kaduri L., Lerer I., et al. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer patients among Ashkenazi women. Am J Hum Genet 60 (1997) 505-514
21. Tobacman J.K., Greene M.H., Tucker M.A., Costa J., Kase R., and Fraumeni Jr. J.F. Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families. Lancet 2 8302 (1982) 795-797
22. Rutter J.L., Wacholder S., Chetrit A., et al. Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study. J Natl Cancer Inst 95 (2003) 1072-1078
23. Rebbeck T.R., Lynch H.T., Neuhausen S.L., et al. Prevention and observation of surgical end points study group. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346 (2002) 1616-1622
24. Kauff N.D., Satagopan J.M., Robson M.E., et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346 (2002) 1609-1615
25. Haber D. Prophylactic oophorectomy to reduce the risk of ovarian and breast cancer in carriers of BRCA mutations. N Engl J Med 346 (2002) 1660-1662
26. Schairer C., Persson I., Falkeborn M., Naessen T., Troisi R., and Brinton L.A. Breast cancer risk associated with gynecologic surgery and indications for such surgery. Int J Cancer 70 (1997) 150-154
27. http://www.health.gov.il/download/icdc/shlemut_maagar.pdf